- 4009 Hackney Springs Ln, Sachse, TX 75048
North Carolina independent labs got a welcome break in 2026—Congress froze the Medicare CLFS rate cuts that were set to slice up to 15% off hundreds of common tests. But that relief comes with a hard deadline: private payor data must be reported to CMS between May 1 and July 31, or labs face penalties up to $10,000 per day.
Meanwhile, Palmetto GBA’s MolDX program hasn’t eased up one bit. Every molecular claim in Jurisdiction M still needs a valid DEX Z-Code, or it gets automatically denied—no exceptions. The Z-Code tells Palmetto exactly which proprietary test was run, while the CPT code only gives the general category. Miss that Z-Code, and you’re looking at a denial that’s tough to appeal.
The rate freeze expires January 1, 2027. If the RESULTS Act doesn’t pass, those 15% cuts could resume. Smart labs are using this window to audit their coding, register tests in DEX, and get reporting data organized now—before the deadline hits.
Running a laboratory’s revenue cycle in North Carolina comes with a fair share of benefits and challenges, confusing labs about taking the right step.
Here’s the good news first: Congress just handed independent labs a breather. Here’s the catch: that breather comes with paperwork, deadlines, and a Medicare contractor in Palmetto GBA that doesn’t forgive sloppy claims. If you bill for molecular or genetic testing in North Carolina, you’re sitting right at the intersection of two big rules: PAMA’s federal fee schedule relief and Palmetto GBA’s MolDX program. Miss a step on either side, and your cash flow takes the hit.
Let’s break down exactly what’s changed, what’s still expected of you, and how to keep your claims clean with North Carolina laboratory billing services through the rest of 2026 and beyond.
Palmetto GBA MolDX phase-in relief is a temporary freeze on Medicare’s Clinical Laboratory Fee Schedule (CLFS) rate cuts, paired with Palmetto GBA’s ongoing MolDX requirements for molecular test billing in Jurisdiction M, which covers North Carolina, South Carolina, Virginia, and West Virginia.
In plain terms, two things are happening at once. On the federal side, Congress froze scheduled rate reductions for 2026. On the regional side, Palmetto GBA still expects every molecular claim to carry a valid DEX Z-Code. One rule protects your rates. The other rule decides whether your claim even gets paid. You need both working in your favor to get clean claim submissions and recover your hard-earned dollars.
On February 3, 2026, the President signed the Consolidated Appropriations Act, 2026. The highlight of this act was Section 6226, which became a lifeline for clinical labs. This provision froze the Medicare Clinical Laboratory Fee Schedule through the end of 2026, heading off cuts that could have sliced up to 15% off nearly 800 commonly billed tests.
Now, the reason for Congress to step in was that the original PAMA reporting system was broken from the start. Fewer than one percent of eligible labs reported data during the first cycle back in 2017, which lowered rates against independent and hospital outreach labs for years. Lawmakers have now delayed the cut schedule six separate times to fix the underlying data problem.
| What Changed | Old Rule | New Rule Under Section 6226 |
|---|---|---|
| 2026 CLFS rate cuts | Up to 15% on ~800 tests | Frozen at 0% through Dec. 31, 2026 |
| Data collection period | January-June 2019 | January 1 - June 30, 2025 |
| Reporting window | Jan. 1 - March 31, 2026 | May 1 - July 31, 2026 |
| Future rate cuts | Immediate | Resume in 2027, capped at 15%/year through 2029 |
Only ‘applicable laboratories’ are required to report data. You likely qualify if your lab received more than $12,500 in CLFS payments during the 2025 collection window and if the majority of your Medicare revenue came from the CLFS or the Physician Fee Schedule.
If that’s your lab, mark your calendar. You’ll need to gather private payor rates and volumes, including Medicare Advantage and Medicaid Managed Care Organization data, from claims paid between January 1 and June 30, 2025. That data gets submitted to CMS between May 1 and July 31, 2026.
Non-reporting labs can face civil monetary penalties of up to $10,000 per day. Beyond the fine, there’s a bigger risk: if too few independent labs report, the 2027 rate calculations get lowered toward national reference labs again, just like they did in 2017.
PAMA sets your baseline national rate. Palmetto GBA, as the Medicare Administrative Contractor for Jurisdiction M, decides whether your claim gets paid at all. Independent labs must not treat these two systems separately. Any molecular diagnostic claim submitted for a patient in one of these states runs through Palmetto’s MolDX Program before it gets adjudicated.
So, MoIDX rates apply when labs under MoIDX jurisdictions submit their Medicare claims to Palmetto GBA. In that case, it’s important to follow Palmetto GBA’s requirements for molecular claims.
| Identifier | What It Tells Palmetto GBA | Where It Lives on the Claim |
|---|---|---|
| CPT / HCPCS / PLA Code | The general test category or tier | Standard procedure code field |
| DEX Z-Code | The exact proprietary test panel performed | Loop 2400 or SV101-7 (837P electronic claim) |
If you don’t add DEX Z-Code to the claim form, Palmetto’s automated system flags the claim as lacking proven clinical utility and denies it outright. Without any manual review, there is no benefit of the doubt. And appealing that denial rarely works.
Industry billing data consistently shows that Z-Code omissions are treated as a front-end coding failure, not a clinical dispute, so the fix has to happen before the claim ever leaves your system. To manage that, you need to invest in professional laboratory billing and coding services from a partner, like TransLabs. Lab billing experts make sure claims are submitted with correct and exact Z-Codes, complying with Palmetto GBA’s MoIDX requirements.
North Carolina’s independent labs got a genuine gift this year: a frozen fee schedule and a bit of breathing room. But it also comes with a challenge. The PAMA reporting deadline is heading fast toward July 31, and Palmetto GBA’s MolDX program isn’t loosening its Z-Code requirements one bit.
To stay on top of all that, don’t just wait and see. Start working proactively. Tighten your front-end coding, register every test in DEX, and get their private payor data in order well before the deadline hits.